| Literature DB >> 28345829 |
Ratha Korn Vilaichone1,2, Thawee Ratanachu ek, Pornpen Gamnarai, Phawinee Subsomwong, Tomahisa Uchida, Yoshio Yamaoka, Varocha Mahachai.
Abstract
Background and aims: Helicobacter pylori (H. pylori) infections, associated with fatal GI diseases such as gastric cancer and MALT lymphoma, remain a major health problem in ASEAN countries. The Golden triangle has long been known as one of Asia’s main opium-producing areas. There have been no prior studies of H. pylori infection in this area. The major objectives of this project were therefore to establish prevalence, antibiotic resistance patterns and associated predictive in the Golden triangle.Entities:
Keywords: Helicobacter pylori; antibiotic resistance; Golden triangle
Year: 2017 PMID: 28345829 PMCID: PMC5454742 DOI: 10.22034/APJCP.2017.18.2.455
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
Figure 1Endoscopy Team in Golden Triangle H. pylori Community Survey
Figure 2Endoscopy Rooms in Community Hospital at Golden Triangle (2 a, 2 b), Golden Triangle Patients Registering before Undergoing Upper GI Endoscopies (2 c)
Demographic Data of All Patients
| Demography | Entire cohort (n= 148) | Antibiotic susceptibility tests (n = 50) | |
|---|---|---|---|
| Sex | |||
| Men | 56 | 20 (35.7%) | 19 |
| Woman | 92 | 33 (35.9%) | 31 |
| Mean Age ± SD (yr) | 56.3±13.3 | 57±13.2 | 55.9±13.9 |
| Range | 21-88 | 24-85 | 24-85 |
| < 40 yr. | 12 | 3 | 4 |
| ≥ 40 yr. | 136 | 50 | 45 |
| Endoscopic finding | |||
| Ulcer | 4 | 2 | 2 |
| NUD | 144 | 51 | 48 |
| Locations | |||
| Chiang saen | 46 | 16 | 18 |
| Chiang khong | 102 | 37 | 32 |
Prevalence of Antibiotic Resistant H. Pylori Strains in Golden Triangle
| Antibiotic n = 50 | Antibiotic resistance (%) |
|---|---|
| Amoxicillin (MIC 0.25 µg/ml) | 0 |
| Clarithromycin (MIC 1 µg/ml) | 1(2%) |
| Metronidazole (MIC 8 µg/ml) | 13 (26%) |
| Tetracycline (MIC 1 µg/ml) | 0 |
| Ciprofloxacin (MIC 1 µg/ml) | 11 (22%) |
| Levofloxacin (MIC 1 µg/ml) | 11 (22%) |
| Multi-drug resistance | 2 (4%) |
Prevalence of Antibiotic Resistant H. Pylori Strains in Each Location
| Antibiotic (n = 50) | Antibiotic resistance (%) | |
|---|---|---|
| Chiang saen (n=18) | Chiang klong (n=32) | |
| Amoxicillin (MIC 0.25 µg/ml) | 0 | 0 |
| Clarithromycin (MIC 1 µg/ml) | 0 | 1 (3.1%) |
| Metronidazole (MIC 8 µg/ml) | 5 (27.8%) | 8 (25%) |
| Tetracycline (MIC 1 µg/ml) | 0 | 0 |
| Ciprofloxacin (MIC 1 µg/ml) | 3 (16.7%) | 8 (25%) |
| Levofloxacin (MIC 1 µg/ml) | 3 (16.7%) | 8 (25%) |
Antibiotic Resistant H. Pylori Strains and Clinical Factors in Golden Triangle People
| Antibiotics | Sex | Age | Endoscopic findings | |||
|---|---|---|---|---|---|---|
| (n = 50) | Female | Male | < 40 years | ≥ 40 years | Gastritis (NUD) | PUD |
| Amoxicillin | ||||||
| resistant | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| susceptible | 31 (62.0%) | 19 (38.0%) | 4 (8%) | 46 (92.0%) | 48 (96.0%) | 2 (4.0%) |
| Clarithromycin | ||||||
| resistant | 0.0 | 1 (100.0%) | 1 (100.0%) | 0.0 | 1 (100.0%) | 0.0 |
| susceptible | 30 (61.2%) | 19 (38.8%) | 4 (8.2%) | 45 (91.8%) | 47 (91.8%) | 2 (8.2%) |
| Metronidazole | ||||||
| resistant | 7 (53.8%) | 6 (46.2%) | 1 (7.7%) | 12 (92.3%) | 13 (100.0%) | 0.0 |
| susceptible | 24 (64.9%) | 13 (35.1%) | 3 (8.1%) | 34 (91.9%) | 35 (94.6%) | 2 (5.4%) |
| Tetracyclin | ||||||
| resistant | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| susceptible | 31 (62.0%) | 19 (38.0%) | 4 (8.0%) | 46 (92.0%) | 48 (96.0%) | 2 (4.0%) |
| Ciprofloxacin | ||||||
| resistant | 8 (72.7%) | 3 (27.3%) | 0.0 | 11 (100.0%) | 11 (100.0%) | 0.0 |
| susceptible | 23 (58.9%) | 16 (41.1%) | 4 (10.3%) | 35 (89.7%) | 37 (34.8%) | 2 (5.2%) |
| Levofloxacin | ||||||
| resistant | 8 (72.7%) | 3 (27.3%) | 0.0 | 11 (100.0%) | 11 (100.0%) | 0.0 |
| susceptible | 23 (58.9%) | 16 (41.1%) | 4 (10.3%) | 35 (89.7%) | 37 (34.8%) | 2 (5.2%) |
P=0.04